biocryst

5 Kommentare / 0 neu
13.03.2007 17:50
#1
Bild des Benutzers schubert
Offline
Kommentare: 204
biocryst

hallo zusammen,

hat irgendjemand von euch aktuelle news zu biocryst?

hab die mal bei 10.20 gekauft und die tümmelten sich lange bei knapp 11 USD rum, seit ein paar Tagen sind sie aber nur noch unter 10 dollars...

gruss

Aufklappen
10.08.2007 18:15
Bild des Benutzers schubert
Offline
Kommentare: 204
biocryst

es geht weiter!!:) 9.89$ +3.12% Blum 3

10.08.2007 00:15
Bild des Benutzers schubert
Offline
Kommentare: 204
biocryst

und biocryst ist auch an einem rabenschwarzen tag wie heute schön im plus!:) aktuell bei $9.60 +0.52%

08.08.2007 19:48
Bild des Benutzers schubert
Offline
Kommentare: 204
biocryst

da hat sich wohl wer erholt!! :twisted: anfangs juli noch unter 7 dollar und nun gehts wieder gegen die 10$ zu!!:)

hängt wohl stark damit zusammen:

BIOCRYST ANNOUNCES $65.3 MILLION PRIVATE PLACEMENT FINANCING

Birmingham, Alabama – August 6, 2007 – BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has signed a definitive agreement to raise $65.3 million in a private placement of approximately 8.3 million shares of its common stock and warrants to purchase an additional approximately 3.2 million shares of common stock. The purchase price for the shares is $7.80 per share, the closing Nasdaq composite bid price for the company's common stock immediately preceding execution of the definitive agreement for the transaction and the exercise price for the warrants is $10.25. Investors in the financing will pay an additional purchase price equal to $0.125 for each share underlying the warrants. The closing of the private placement is subject to certain closing conditions.

Participants in the transaction include funds managed by Baker Brothers Investments, Kleiner Perkins Caufield & Byers, EHS Holdings, OrbiMed Advisors, Texas Pacific Group Ventures, and Stephens Investment Management.

"We are gratified by the strong support we received from this group of existing shareholders," said Jon P. Stonehouse, Chief Executive Officer of BioCryst. "The completion of the offering is a vote of confidence in the company's future and strengthens our balance sheet allowing us to bolster the company's fundamentals. BioCryst is now in a stronger position to execute on our plans, advancing key development programs through late-stage human trials while also mining our productive discovery engine for new compounds to move into the clinic."

Ausserdem entwickeln sich auch die Produkte in der Pipeline sehr gut, haben einige vielverspechende Medikamente!!:)

28.03.2007 08:11
Bild des Benutzers schubert
Offline
Kommentare: 204
biocryst

biocryst hat gestern knapp 17% verloren!! :roll:

finde leider absolut keine News...